Asacol Magasýruþolin tafla 400 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

asacol magasýruþolin tafla 400 mg

tillotts pharma ab - mesalazinum inn - magasýruþolin tafla - 400 mg

Asacol Magasýruþolin tafla 800 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

asacol magasýruþolin tafla 800 mg

tillotts pharma ab - mesalazinum inn - magasýruþolin tafla - 800 mg

Penthrox Innöndunargufa, gegndreyptur stabbi 3 ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

penthrox innöndunargufa, gegndreyptur stabbi 3 ml

medical developments ned b.v. - methoxyflurane - innöndunargufa, gegndreyptur stabbi - 3 ml

Toilax Sýruþolin tafla og endaþarmsdreifa Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

toilax sýruþolin tafla og endaþarmsdreifa

orion corporation - bisacodylum inn - sýruþolin tafla og endaþarmsdreifa

Thiamazole Uni-Pharma Tafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

thiamazole uni-pharma tafla 5 mg

uni-pharma kleon tsetis pharmaceutical laboratories s.a. - thiamazolum inn - tafla - 5 mg

Qdenga Evrópusambandið - íslenska - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - fjölmörgum - bóluefni - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.